• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device stent graft, bypass, superficial femoral artery
Definition For bypassing stenosis in the superficial femoral artery via the femoral vein
Product CodeQWM
Device Class 3

Premarket Approvals (PMA)
2021 2022 2023 2024 2025 2026
0 0 2 1 5 1

MDR Year MDR Reports MDR Events
2023 1 1
2024 16 16
2025 8 8
2026 1 1

Device Problems MDRs with this Device Problem Events in those MDRs
Complete Blockage 5 5
Migration 4 4
Device Stenosis 4 4
Unintended Movement 3 3
Activation Failure 3 3
Malposition of Device 3 3
Noise, Audible 2 2
Difficult to Remove 2 2
Failure to Unfold or Unwrap 2 2
Obstruction of Flow 2 2
Partial Blockage 1 1
Adverse Event Without Identified Device or Use Problem 1 1
Insufficient Information 1 1
Loosening of Implant Not Related to Bone-Ingrowth 1 1
Lack of Effect 1 1
Migration or Expulsion of Device 1 1
Difficult or Delayed Activation 1 1
Activation, Positioning or Separation Problem 1 1
Detachment of Device or Device Component 1 1
Difficult to Advance 1 1
Device Dislodged or Dislocated 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
Obstruction/Occlusion 9 9
No Clinical Signs, Symptoms or Conditions 7 7
Pain 7 7
Thrombosis/Thrombus 5 5
Failure of Implant 2 2
Insufficient Information 2 2
Stenosis 2 2
Sepsis 1 1
Necrosis 1 1
Ischemia 1 1
Retroperitoneal Hemorrhage 1 1
Respiratory Failure 1 1

-
-